• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射钾盐坎利酸钾对重度心力衰竭合并洋地黄中毒患者的影响。

The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.

作者信息

Cristodorescu R, Puschita M, Deutsch G, Berger E, Luca C

出版信息

Med Interne. 1977 Jan-Mar;15(1):27-34.

PMID:841250
Abstract

In 16 patients with critical condition due to severe heart failure associated with digitalis toxicity, the effects of potassium canrenoate (AldactoneR) administered intravenously were studied. Rhythm and conduction disturbances disappeared or improved in all instances. This effect was well correlated with an increase of serum potassium concentration. In 13 patients, after 1-2 days of Aldactone therapy, heart failure improved, which could be explained by a diuretic effect and by a possible inotropic action of aldactone. It is concluded that intravenous Aldactone is useful in patients with severe heart failure and digitalis toxicity in whom diuretics are often ineffective and even dangerous.

摘要

对16例因严重心力衰竭合并洋地黄中毒而病情危急的患者,研究了静脉注射螺内酯(安体舒通)的效果。所有病例的节律和传导紊乱均消失或改善。这种效果与血清钾浓度的升高密切相关。13例患者在接受螺内酯治疗1 - 2天后,心力衰竭得到改善,这可能是由于利尿作用以及螺内酯可能的正性肌力作用。得出结论,静脉注射螺内酯对重度心力衰竭合并洋地黄中毒的患者有用,这类患者使用利尿剂往往无效甚至危险。

相似文献

1
The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.静脉注射钾盐坎利酸钾对重度心力衰竭合并洋地黄中毒患者的影响。
Med Interne. 1977 Jan-Mar;15(1):27-34.
2
Treatment of digitalis toxicity with intravenous potassium canrenoate.静脉注射钾螺内酯治疗洋地黄中毒。
Agressologie. 1977;18(3):167-71.
3
Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.坎利酮——螺内酯的一种代谢产物。对洋地黄化患者的急性心脏效应。
Eur J Cardiol. 1979 Aug;10(2):143-9.
4
Single-dose i.v. Aldactone for congestive heart failure: a preliminary observation.静脉注射单剂量安体舒通治疗充血性心力衰竭:初步观察
Int J Clin Pharmacol Ther Toxicol. 1983 Aug;21(8):417-21.
5
Antiarrhythmic activity of potassium canrenoate in man.安体舒通钾对人体的抗心律失常作用
Am Heart J. 1976 Sep;92(3):308-14. doi: 10.1016/s0002-8703(76)80112-3.
6
[Study of the inotropic effect of potassium-canrenoate by systolic time intervals technique (author's transl)].用收缩期时间间期技术研究安体舒通钾的变力效应(作者译)
G Ital Cardiol. 1980;10(10):1360-5.
7
[Aldosterone antagonists in coronary insufficiency].[醛固酮拮抗剂在冠状动脉功能不全中的应用]
Med Klin. 1978 Jan 20;73(3):84-8.
8
[Extrarenal effects of potassium-canrenoate. Haemodynamic investigations during neuroleptanalgesia in cardiosurgical patients (author's transl)].[安体舒通钾的肾外作用。心脏手术患者神经安定镇痛期间的血流动力学研究(作者译)]
Anaesthesist. 1979 Apr;28(4):163-70.
9
[Value of potassium canrenoate in the prevention of arrhythmia during the acute phase of myocardial infarction].[安体舒通钾在预防心肌梗死急性期心律失常中的价值]
Arch Mal Coeur Vaiss. 1979 Sep;72(9):1014-22.
10
[Efficacy of canrenoate potassium in hypertensive cardiopathy. Clinical and echocardiographic evaluation].[坎利酸钾在高血压性心脏病中的疗效。临床及超声心动图评估]
Minerva Cardioangiol. 1984 Sep;32(9):581-7.